0.7700SEK-2.90%Mkt Cap: 189.40M SEKP/E: —Last update: 2026-06-01
Klaria Pharma Holding AB (publ.), a pharmaceutical company develops and commercializes medication for migraine and cancer related pain, and opioid overdose and anaphylactic shock. Its product pipeline includes Sumatripta…
Industry Peers
Drug Manufacturers - Specialty & Generic150.78BSEKP/E 166.4
58.93BTRY—
56.89BEURP/E 22.4
32.78BPLNP/E 21.4
23.20BUSDP/E 20.2
18.39BUSD—
16.21BUSDP/E 24.8
13.00BTRY—
Indicators:|
Key Statistics
Company
Market Cap189.40M SEK
Enterprise Value195.34M SEK
Revenue (TTM)8.98M SEK
Gross Profit8.98M SEK
Net Income (TTM)-38.89M SEK
Revenue/Share0.0480 SEK
Last Price0.7700 SEK
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees4
CountrySE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINSE0007280326
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-13.94
EV/Revenue21.74
P/S21.71
P/B-49.56
EPS (TTM)-0.21
EPS (Forward)0.00
52W Range
0.392840% of range1.330
52W High1.330 SEK
52W Low0.3928 SEK
Profitability
Gross Margin100.00%
Oper. Margin-50271.43%
EBITDA Margin-156.02%
Profit Margin-432.80%
ROE1004.05%
ROA-95.39%
Growth
Revenue Growth-99.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-35.04M SEK
CapEx (TTM)—
FCF Margin17.85%
FCF Yield0.85%
Net Debt275.00K SEK
Net Debt/EBITDA-0.02
Balance Sheet
Debt/Equity—
Current Ratio0.05
Quick Ratio0.05
Book Value/Sh-0.0160 SEK
Cash/Share0.0010 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.245.98M
Float211.46M
Insiders17.40%
Institutions7.38%
Technical
SMA 500.9033 (-14.8%)
SMA 2000.7295 (+5.6%)
Beta1.20
S&P 52W Chg27.70%
Avg Vol (30d)1.03M
Avg Vol (10d)1.14M
Technical Indicators
RSI (14)42.9
MACD-0.0317
MACD Signal-0.0289
MACD Hist.-0.0027
BB Upper0.9181 SEK
BB Middle0.8289 SEK
BB Lower0.7398 SEK
BB Width21.52%
ATR (14)0.0795 SEK
Vol Ratio (20d)1.39x